ENSC
NASD Ensysce Biosciences, Inc.$0.5897 ↑ +0.0338 (+6.08%) Trading Up from the previous close of $0.5559, $0.0203 below the day’s high of $0.6100
- YTD change
- -35.90%
- vs 20-day SMA
- +35.02%
- vs 200-day SMA
- +26.26%
Price ranges
Price & Performance
+0.00 (+0.85%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $5,136.0000
- ENSC is down 36% since the beginning of the year
- ENSC is down 75% over the past 12 months
- ENSC is up 22% over the past 1 month
- 6% of all ENSC investors are betting against ENSC
ENSC reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -76.0%.
- Previous minute
- -$0.0055
- Last hour
- +$0.0577
- Last 5 days
- +40.74%
- vs 8-day SMA
- +30.54%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
